Skip to main content
Premium Trial:

Request an Annual Quote

Biomagnetics Diagnostics Licenses Biosensor IP from Los Alamos

NEW YORK (GenomeWeb News) – Biomagnetics Diagnostics said yesterday that it has acquired rights to intellectual property from Los Alamos National Laboratory related to biosensor and multiplex diagnostics technologies.

San Francisco-based Biomagnetics said that it plans to use the IP for the development of a handheld, integrated optical biosensor for highly accurate and rapid diagnosis of HIV/AIDS, malaria, tuberculosis, and other pathogens.

The IP acquisition follows a licensing deal that the firm inked with Los Alamos earlier this week, under which it gained access to optical biosensor technology developed at the lab. The new agreement covers IP for quantitative multiplex detection of pathogen biomarkers.

Biomagnetics has developed a high-throughput screening magnetic testing platform that provides qualitative and quantitative results from a single test, according to the firm's website. The platform detects viruses by measuring the magnetic field of micro-particles bonded to the virus "in a fraction of the time and costs of existing assays," it said.

Terms of the licenses were not disclosed.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.